Novanta
Global supplier of photonics, laser processing, and precision motion subsystems for medical and advanced industrial OEMs, including beam delivery and scan head solutions specifically for laser additive manufacturing.
- CEO / Founder
- Matthijs Glastra
- Team Size
- 1001-5000
- Stage
- Public
- Total Funding
- $300.0M
- Latest Round
- Post-IPO
Technology & Products
Key Products
FireFly3D scan head; Cambridge Technology galvo scanners; Synrad CO2 lasers; Solid-state & ultrafast lasers; High-precision encoders and motion control systems
Technological Advantage
Novanta combines decades of laser and motion control expertise with application knowledge in medical and industrial OEM environments. Its FireFly3D scan head integrates quality assurance directly into the scanning system, a differentiator that reduces the need for separate process monitoring hardware. The advantage is supported by proprietary design know-how and strong OEM relationships, but is not protected by a single broad patent; it is a systems integration and application engineering moat, which is replicable by well-funded component rivals like SCANLAB or MKS.
Differentiation
Value Proposition
Provides proven, application-specific laser scanning heads, lasers, and motion control components that reduce AM system integration time, improve print reliability, and enable in-situ quality monitoring; helps equipment builders reach market faster with lower engineering risk.
How They Differentiate
Offers a broader integrated portfolio (scan heads, lasers, motion control, encoders) than scanner-only specialists like SCANLAB, while providing medical-grade quality and long-term OEM support. FireFly3D embeds in-situ QA, a feature not standard in competitive scan heads.
Market & Competition
Target Customers
OEMs of medical devices, life sciences instrumentation, and advanced industrial equipment, including additive manufacturing system manufacturers
Industry Verticals
Medical; Life Sciences; Industrial Manufacturing; Additive Manufacturing; Aerospace & Defense; Semiconductor; Robotics & Automation
Competitors
SCANLAB GmbH; Raylase AG; MKS Instruments (Newport/Spectra-Physics); Coherent (II-VI)
Growth & Milestones
Growth Metrics
Revenue grew 5.6% YoY; 50%+ of revenue from medical markets; 5-7% organic growth target.
Major Milestones
2016: GSI Group renamed to Novanta Inc.; 2018: 10-K cites additive manufacturing as an advanced industrial application; 2023: Acquired Motion Solutions to expand motion control capabilities; 2025: Announced offering of Tangible Equity Units; 2026: Announced agreement to acquire Riverpoint Medical for $1.45 billion ($1.2B upfront)